John Antonydas Gaspar

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach

Anne K. Krug, Raivo Kolde, John Antonydas Gaspar et al. · Archives of Toxicology · 2012 · 238 citations · Full text

Pharmacy, Developmental Biology, Toxicology +17

Design Principles of Concentration-Dependent Transcriptome Deviations in Drug-Exposed Differentiating Stem Cells

Tanja Waldmann, Eugen Rempel, Nina V. Balmer et al. · Chemical Research in Toxicology · 2014 · 110 citations · Full text

Life Sciences, Systems Biology, Toxicology +17

Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment

Umesh Chaudhari, Harshal Nemade, Vilas Wagh et al. · Archives of Toxicology · 2015 · 106 citations · Full text

Medicine, Pharmacology, Toxicology +17

Identification of Thalidomide-Specific Transcriptomics and Proteomics Signatures during Differentiation of Human Embryonic Stem Cells

Kesavan Meganathan, Smita Jagtap, Vilas Wagh et al. · PLoS ONE · 2012 · 93 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17

MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes

Umesh Chaudhari, Harshal Nemade, John Antonydas Gaspar et al. · Archives of Toxicology · 2016 · 91 citations · Full text

Life Sciences, Pharmacology, Toxicology +15